|
C7ORF60 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.95650000000192E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.580800E-04 |
| Normal-vs-Stage2 |
1.045530E-02 |
| Normal-vs-Stage3 |
2.439200E-04 |
| Normal-vs-Stage4 |
9.30120000020018E-07 |
| Stage1-vs-Stage2 |
9.621000E-01 |
| Stage1-vs-Stage3 |
4.307000E-01 |
| Stage1-vs-Stage4 |
7.740600E-03 |
| Stage2-vs-Stage3 |
5.791400E-01 |
| Stage2-vs-Stage4 |
6.952300E-02 |
| Stage3-vs-Stage4 |
9.630300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.248699999996E-05 |
| Normal-vs-AfricanAmerican |
1.788110E-02 |
| Normal-vs-Asian |
1.537480E-03 |
| Caucasian-vs-AfricanAmerican |
8.622000E-01 |
| Caucasian-vs-Asian |
9.401000E-01 |
| AfricanAmerican-vs-Asian |
9.140200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.50039999999541E-05 |
| Normal-vs-Female |
1.021020E-04 |
| Male-vs-Female |
8.492000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.759100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.575010E-04 |
| Normal-vs-Age(61-80Yrs) |
8.23750000000789E-05 |
| Normal-vs-Age(81-100Yrs) |
1.824170E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.417000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.006000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.381600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.278400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.923800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.482200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.256200E-02 |
| Classical-VS-Follicular |
2.809200E-01 |
| Classical-VS-Other |
9.121000E-01 |
| Classical-VS-Normal |
5.843900E-04 |
| Tall-VS-Follicular |
2.333000E-01 |
| Tall-VS-Other |
3.465000E-01 |
| Tall-VS-Normal |
1.157440E-04 |
| Follicular-VS-Other |
8.237800E-01 |
| Follicular-VS-Normal |
8.194000E-04 |
| Other-VS-Normal |
1.791550E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.02909999999346E-05 |
| Normal-vs-N1 |
2.46989999999059E-05 |
| N0-vs-N1 |
2.914800E-01 |
|
|
